Reference Type:  Journal Article
Record Number: 1007
Author: Braskie, M. N. and Thompson, P. M.
Year: 2014
Title: A focus on structural brain imaging in the Alzheimer's Disease Neuroimaging Initiative
Journal: Biological Psychiatry
Volume: 75
Issue: 7
Pages: 527-533
Short Title: A focus on structural brain imaging in the Alzheimer's Disease Neuroimaging Initiative
ISSN: 18732402 (ISSN)
DOI: 10.1016/j.biopsych.2013.11.020
Keywords: Alzheimer's disease
atrophy
biomarkers
brain volume
cognition
cognitive decline
conversion
dementia
hippocampus
magnetic resonance imaging
mild cognitive impairment
MRI
predict
progression
temporal lobe
Alzheimer disease
cognitive defect
diagnosis related group
disease course
disease marker
environmental factor
genetic risk
human
neuroimaging
nuclear magnetic resonance imaging
outcome assessment
priority journal
review
risk factor
Abstract: In recent years, numerous laboratories and consortia have used neuroimaging to evaluate the risk for and progression of Alzheimer's disease (AD). The Alzheimer's Disease Neuroimaging Initiative is a longitudinal, multicenter study that is evaluating a range of biomarkers for use in diagnosis of AD, prediction of patient outcomes, and clinical trials. These biomarkers include brain metrics derived from magnetic resonance imaging (MRI) and positron emission tomography scans as well as metrics derived from blood and cerebrospinal fluid. We focus on Alzheimer's Disease Neuroimaging Initiative studies published between 2011 and March 2013 for which structural MRI was a major outcome measure. Our main goal was to review key articles offering insights into progression of AD and the relationships of structural MRI measures to cognition and to other biomarkers in AD. In Supplement 1, we also discuss genetic and environmental risk factors for AD and exciting new analysis tools for the efficient evaluation of large-scale structural MRI data sets such as the Alzheimer's Disease Neuroimaging Initiative data. Â© 2014 Society of Biological Psychiatry.
Notes: Cited By (since 1996):1
Export Date: 28 May 2014
Source: Scopus
CODEN: BIPCB
Language of Original Document: English
Correspondence Address: Thompson, P.M.; Imaging Genetics Center, Keck School of Medicine, University of Southern California, 4676 Admiralty Way, Marina Del Rey, CA 90292, United States; email: pthomp@usc.edu
References: Ellis, K.A., Bush, A.I., Darby, D., De Fazio, D., Foster, J., Hudson, P., The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease (2009) Int Psychogeriatr, 21, pp. 672-687; Lunetta, K.L., Erlich, P.M., Cuenco, K.T., Cupples, L.A., Green, R.C., Farrer, L.A., Decarli, C., Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study (2007) Alzheimer Dis Assoc Disord, 21, pp. 85-91; Winblad, B., Frisoni, G.B., Frolich, L., Johannsen, P., Johansson, G., Kehoe, P., Editorial: EADC (European Alzheimer Disease Consortium) recommendations for future Alzheimer disease research in Europe (2008) J Nutr Health Aging, 12, pp. 683-684; Weiner, M.W., Veitch, D.P., Aisen, P.S., Beckett, L.A., Cairns, N.J., Green, R.C., The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2013) Alzheimers Dement, 9, pp. 111-e194; Braskie, M.N., Ringman, J.M., Thompson, P.M., Neuroimaging measures as endophenotypes in Alzheimer's disease (2011) Int J Alzheimers Dis, 2011, p. 490140; Shen, L., Thompson, P.M., Potkin, S.G., Bertram, L., Farrer, L.A., Foroud, T.M., Genetic analysis of quantitative phenotypes in AD and MCI: Imaging, cognition and biomarkers [published online ahead of print Oct 5] (2013) Brain Imaging Behav; Braskie, M.N., Toga, A.W., Thompson, P.M., Recent advances in imaging Alzheimer's disease (2013) J Alzheimers Dis, 33 (SUPPL. 1), pp. 313-S327; Vernooij, M.W., Smits, M., Structural neuroimaging in aging and Alzheimer's disease (2012) Neuroimaging Clin N Am, 22, pp. 33-55; Schuur, M., Van Swieten, J.C., Schol-Gelok, S., Ikram, M.A., Vernooij, M.W., Liu, F., Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population (2011) J Neurol Neurosurg Psychiatry, 82, pp. 41-44; Braskie, M.N., Thompson, P.M., Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings (2013) Trends Cogn Sci, 17, pp. 510-516; Fjell, A.M., Walhovd, K.B., New tools for the study of Alzheimer's disease: What are biomarkers and morphometric markers teaching us? (2011) Neuroscientist, 17, pp. 592-605; Jack, Jr.C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade (2010) Lancet Neurol, 9, pp. 119-128; Jack, Jr.C.R., Knopman, D.S., Jagust, W.J., Petersen, R.C., Weiner, M.W., Aisen, P.S., Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers (2013) Lancet Neurol, 12, pp. 207-216; Braak, H., Braak, E., Frequency of stages of Alzheimer-related lesions in different age categories (1997) Neurobiol Aging, 18, pp. 351-357; Knopman, D.S., Jack, Jr.C.R., Wiste, H.J., Weigand, S.D., Vemuri, P., Lowe, V.J., Brain injury biomarkers are not dependent on beta-amyloid in normal elderly (2013) Ann Neurol, 73, pp. 472-480; Lo, R.Y., Hubbard, A.E., Shaw, L.M., Trojanowski, J.Q., Petersen, R.C., Aisen, P.S., Longitudinal change of biomarkers in cognitive decline (2011) Arch Neurol, 68, pp. 1257-1266; Landau, S.M., Mintun, M.A., Joshi, A.D., Koeppe, R.A., Petersen, R.C., Aisen, P.S., Amyloid deposition, hypometabolism, and longitudinal cognitive decline (2012) Ann Neurol, 72, pp. 578-586; Jack, Jr.C.R., Vemuri, P., Wiste, H.J., Weigand, S.D., Aisen, P.S., Trojanowski, J.Q., Evidence for ordering of Alzheimer disease biomarkers (2011) Arch Neurol, 68, pp. 1526-1535; Caroli, A., Frisoni, G.B., The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort (2010) Neurobiol Aging, 31, pp. 1263-1274; Ewers, M., Insel, P., Jagust, W.J., Shaw, L., Trojanowski, J.Q., Aisen, P., CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects (2012) Cerebral Cortex, 22, pp. 1993-2004; Han, S.D., Gruhl, J., Beckett, L., Dodge, H.H., Stricker, N.H., Farias, S., Beta amyloid, tau, neuroimaging, and cognition: Sequence modeling of biomarkers for Alzheimer's disease (2012) Brain Imaging Behav, 6, pp. 610-620; Sabuncu, M.R., Desikan, R.S., Sepulcre, J., Yeo, B.T., Liu, H., Schmansky, N.J., The dynamics of cortical and hippocampal atrophy in Alzheimer disease (2011) Arch Neurol, 68, pp. 1040-1048; Chiang, G.C., Insel, P.S., Tosun, D., Schuff, N., Truran-Sacrey, D., Raptentsetsang, S.T., Impact of ApoE4-CSF Abeta interaction on hippocampal volume loss over 1 year in MCI (2011) Alzheimer Dement, 7, pp. 514-520; Carmichael, O., McLaren, D.G., Tommet, D., Mungas, D., Jones, R.N., Coevolution of brain structures in amnestic mild cognitive impairment (2012) Neuroimage, 66 C, pp. 449-456; Buchhave, P., Minthon, L., Zetterberg, H., Wallin, A.K., Blennow, K., Hansson, O., Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia (2012) Arch Gen Psychiatry, 69, pp. 98-106; Mormino, E.C., Kluth, J.T., Madison, C.M., Rabinovici, G.D., Baker, S.L., Miller, B.L., Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects (2009) Brain, 132, pp. 1310-1323; Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Gene dose of apolipoprotein e type 4 allele and the risk of Alzheimer's disease in late onset families (1993) Science, 261, pp. 921-923; Protas, H.D., Chen, K., Langbaum, J.B., Fleisher, A.S., Alexander, G.E., Lee, W., Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease (2013) JAMA Neurol, 70, pp. 320-325; Reiman, E.M., Chen, K., Alexander, G.E., Caselli, R.J., Bandy, D., Osborne, D., Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia (2004) Proc Natl Acad Sci U S A, 101, pp. 284-289; Fleisher, A.S., Chen, K., Liu, X., Ayutyanont, N., Roontiva, A., Thiyyagura, P., Apolipoprotein e epsilon4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease (2013) Neurobiol Aging, 34, pp. 1-12; Jagust, W., Apolipoprotein E, neurodegeneration, and Alzheimer disease (2013) JAMA Neurol, 70, pp. 299-300; Bateman, R.J., Xiong, C., Benzinger, T.L., Fagan, A.M., Goate, A., Fox, N.C., Clinical and biomarker changes in dominantly inherited Alzheimer's disease (2012) N Engl J Med, 367, pp. 795-804; Schuff, N., Tosun, D., Insel, P.S., Chiang, G.C., Truran, D., Aisen, P.S., Nonlinear time course of brain volume loss in cognitively normal and impaired elders (2012) Neurobiol Aging, 33, pp. 845-855; Jack, Jr.C.R., Lowe, V.J., Weigand, S.D., Wiste, H.J., Senjem, M.L., Knopman, D.S., Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease (2009) Brain, 132, pp. 1355-1365; Mouiha, A., Duchesne, S., Toward a dynamic biomarker model in Alzheimer's disease (2012) J Alzheimer Dis, 30, pp. 91-100; Thompson, W.K., Hallmayer, J., O'Hara, R., Design considerations for characterizing psychiatric trajectories across the lifespan: Application to effects of APOE-epsilon4 on cerebral cortical thickness in Alzheimer's disease (2011) Am J Psychiatry, 168, pp. 894-903; Holland, D., Desikan, R.S., Dale, A.M., McEvoy, L.K., Rates of decline in Alzheimer disease decrease with age (2012) PLoS One, 7, p. 42325; Samtani, M.N., Farnum, M., Lobanov, V., Yang, E., Raghavan, N., Dibernardo, A., Narayan, V., An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative (2012) J Clin Pharmacol, 52, pp. 629-644; Song, X., Mitnitski, A., Zhang, N., Chen, W., Rockwood, K., Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative (2013) J Neurol Neurosurg Psychiatry, 84, pp. 71-78; Stonnington, C.M., Chu, C., Kloppel, S., Jack, Jr.C.R., Ashburner, J., Frackowiak, R.S., Predicting clinical scores from magnetic resonance scans in Alzheimer's disease (2010) Neuroimage, 51, pp. 1405-1413; Dickerson, B.C., Wolk, D.A., Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics (2011) J Neurol Neurosurg Psychiatry, 82, pp. 45-51; Evans, M.C., Barnes, J., Nielsen, C., Kim, L.G., Clegg, S.L., Blair, M., Volume changes in Alzheimer's disease and mild cognitive impairment: Cognitive associations (2010) Eur Radiol, 20, pp. 674-682; Nho, K., Risacher, S.L., Crane, P.K., Decarli, C., Glymour, M.M., Habeck, C., Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease (2012) Brain Imaging Behav, 6, pp. 551-567; Rowe, C.C., Ellis, K.A., Rimajova, M., Bourgeat, P., Pike, K.E., Jones, G., Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging (2010) Neurobiol Aging, 31, pp. 1275-1283; Apostolova, L.G., Morra, J.H., Green, A.E., Hwang, K.S., Avedissian, C., Woo, E., Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects (2010) Neuroimage, 51, pp. 488-499; Leow, A.D., Yanovsky, I., Parikshak, N., Hua, X., Lee, S., Toga, A.W., Alzheimer's disease neuroimaging initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition (2009) Neuroimage, 45, pp. 645-655; Carmichael, O., Xie, J., Fletcher, E., Singh, B., Decarli, C., Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume (2012) Neurobiol Aging, 33 (1124), pp. 31-41; Guzman, V.A., Carmichael, O.T., Schwarz, C., Tosto, G., Zimmerman, M.E., Brickman, A.M., White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment (2013) Alzheimer Dement, 9 (5 SUPPL.), pp. 124-S131; Tosun, D., Schuff, N., Shaw, L.M., Trojanowski, J.Q., Weiner, M.W., Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data (2011) J Alzheimer Dis, 26 (SUPPL. 3), pp. 77-90; Apostolova, L.G., Hwang, K.S., Andrawis, J.P., Green, A.E., Babakchanian, S., Morra, J.H., 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects (2010) Neurobiol Aging, 31, pp. 1284-1303; Stricker, N.H., Dodge, H.H., Dowling, N.M., Han, S.D., Erosheva, E.A., Jagust, W.J., CSF biomarker associations with change in hippocampal volume and precuneus thickness: Implications for the Alzheimer's pathological cascade (2012) Brain Imaging Behav, 6, pp. 599-609; Varges, D., Jung, K., Gawinecka, J., Heinemann, U., Schmitz, M., Von Ahsen, N., Amyloid-beta 1-42 levels are modified by apolipoprotein e epsilon4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease (2011) J Alzheimer Dis, 23, pp. 717-726; Prince, J.A., Zetterberg, H., Andreasen, N., Marcusson, J., Blennow, K., APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42 (2004) Neurology, 62, pp. 2116-2118; Hostage, C.A., Roy Choudhury, K., Doraiswamy, P.M., Petrella, J.R., Dissecting the gene dose-effects of the APOE epsilon4 and epsilon2 alleles on hippocampal volumes in aging and Alzheimer's disease (2013) PLoS One, 8, p. 54483; Burggren, A.C., Zeineh, M.M., Ekstrom, A.D., Braskie, M.N., Thompson, P.M., Small, G.W., Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein e e4 carriers (2008) Neuroimage, 41, pp. 1177-1183; Liu, Y., Paajanen, T., Westman, E., Wahlund, L.O., Simmons, A., Tunnard, C., Effect of APOE epsilon4 allele on cortical thicknesses and volumes: The AddNeuroMed study (2010) J Alzheimer Dis, 21, pp. 947-966; Mueller, S.G., Weiner, M.W., Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields (2009) Hippocampus, 19, pp. 558-564; Morra, J.H., Tu, Z., Apostolova, L.G., Green, A.E., Avedissian, C., Madsen, S.K., Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls (2009) Neuroimage, 45, pp. 3-S15; Schuff, N., Woerner, N., Boreta, L., Kornfield, T., Shaw, L.M., Trojanowski, J.Q., MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers (2009) Brain, 132, pp. 1067-1077; Ziegler, G., Dahnke, R., Gaser, C., Models of the aging brain structure and individual decline (2012) Front Neuroinform, 6, p. 3; Chiang, G.C., Insel, P.S., Tosun, D., Schuff, N., Truran-Sacrey, D., Raptentsetsang, S., Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes (2011) Radiology, 259, pp. 844-851; Dickerson, B.C., Wolk, D.A., MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults (2012) Neurology, 78, pp. 84-90; Nettiksimmons, J., Harvey, D., Brewer, J., Carmichael, O., Decarli, C., Jack, Jr.C.R., Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline (2010) Neurobiol Aging, 31, pp. 1419-1428; Murphy, E.A., Holland, D., Donohue, M., McEvoy, L.K., Hagler, Jr.D.J., Dale, A.M., Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls (2010) Neuroimage, 53, pp. 1310-1317; Smith, C.D., Andersen, A.H., Gold, B.T., Structural brain alterations before mild cognitive impairment in ADNI: Validation of volume loss in a predefined antero-temporal region (2012) J Alzheimer Dis, 31 (SUPPL. 3), pp. 49-S58; Lehmann, M., Koedam, E.L., Barnes, J., Bartlett, J.W., Barkhof, F., Wattjes, M.P., Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers (2013) Neurobiol Aging, 34, pp. 73-82; Macdonald, K.E., Bartlett, J.W., Leung, K.K., Ourselin, S., Barnes, J., The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD (2013) Alzheimer Dis Assoc Disord, 27, pp. 168-173; Greene, S.J., Killiany, R.J., Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease (2010) Neurobiol Aging, 31, pp. 1304-1311; Risacher, S.L., Saykin, A.J., West, J.D., Shen, L., Firpi, H.A., McDonald, B.C., Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort (2009) Curr Alzheimer Res, 6, pp. 347-361; Zhang, N., Song, X., Zhang, Y., Chen, W., D'Arcy, R.C., Darvesh, S., An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: A follow-up study (2011) J Alzheimer Dis, 26 (SUPPL. 3), pp. 359-367; Davatzikos, C., Bhatt, P., Shaw, L.M., Batmanghelich, K.N., Trojanowski, J.Q., Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification (2011) Neurobiol Aging, 32 (2322), pp. 19-27; Zhang, N., Song, X., Zhang, Y., Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment (2012) Dement Geriatr Cogn Disord, 33, pp. 318-326; Westman, E., Aguilar, C., Muehlboeck, J.S., Simmons, A., Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment (2013) Brain Topogr, 26, pp. 9-23; Westman, E., Simmons, A., Muehlboeck, J.S., Mecocci, P., Vellas, B., Tsolaki, M., AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America (2011) Neuroimage, 58, pp. 818-828; Spulber, G., Simmons, A., Muehlboeck, J.S., Mecocci, P., Vellas, B., Tsolaki, M., An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment (2013) J Intern Med, 273, pp. 396-409; Aksu, Y., Miller, D.J., Kesidis, G., Bigler, D.C., Yang, Q.X., An MRI-derived definition of MCI-to-AD conversion for long-term, automatic prognosis of MCI patients (2011) PLoS One, 6, p. 25074; Chincarini, A., Bosco, P., Calvini, P., Gemme, G., Esposito, M., Olivieri, C., Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease (2011) Neuroimage, 58, pp. 469-480; Li, Y., Wang, Y., Wu, G., Shi, F., Zhou, L., Lin, W., Shen, D., Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features (2012) Neurobiol Aging, 33 (427), pp. 15-30; Querbes, O., Aubry, F., Pariente, J., Lotterie, J.A., Demonet, J.F., Duret, V., Early diagnosis of Alzheimer's disease using cortical thickness: Impact of cognitive reserve (2009) Brain, 132, pp. 2036-2047; Wee, C.Y., Yap, P.T., Shen, D., Prediction of Alzheimer's disease and mild cognitive impairment using cortical morphological patterns (2013) Hum Brain Mapp, 34, pp. 3411-3425; Eskildsen, S.F., Coupe, P., Garcia-Lorenzo, D., Fonov, V., Pruessner, J.C., Collins, D.L., Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning (2013) Neuroimage, 65, pp. 511-521; Westman, E., Muehlboeck, J.S., Simmons, A., Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion (2012) Neuroimage, 62, pp. 229-238; Yang, X., Tan, M.Z., Qiu, A., CSF and brain structural imaging markers of the Alzheimer's pathological cascade (2012) PLoS One, 7, p. 47406; Walhovd, K.B., Fjell, A.M., Brewer, J., McEvoy, L.K., Fennema-Notestine, C., Hagler, Jr.D.J., Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease (2010) AJNR Am J Neuroradiol, 31, pp. 347-354; Zhang, D., Shen, D., Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease (2012) Neuroimage, 59, pp. 895-907; Schmand, B., Eikelenboom, P., Van Gool, W.A., Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment (2012) J Alzheimer Dis, 29, pp. 641-648; Gross, A.L., Manly, J.J., Pa, J., Johnson, J.K., Park, L.Q., Mitchell, M.B., Cortical signatures of cognition and their relationship to Alzheimer's disease (2012) Brain Imaging Behav, 6, pp. 584-598; Devanand, D.P., Liu, X., Brown, P.J., Huey, E.D., Stern, Y., Pelton, G.H., A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease (2012) Int J Alzheimer Dis, 2012, p. 483469; Hinrichs, C., Singh, V., Xu, G., Johnson, S.C., Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population (2011) Neuroimage, 55, pp. 574-589; Heister, D., Brewer, J.B., Magda, S., Blennow, K., McEvoy, L.K., Predicting MCI outcome with clinically available MRI and CSF biomarkers (2011) Neurology, 77, pp. 1619-1628; Zhou, B., Nakatani, E., Teramukai, S., Nagai, Y., Fukushima, M., Risk classification in mild cognitive impairment patients for developing Alzheimer's disease (2012) J Alzheimer Dis, 30, pp. 367-375; Cui, Y., Liu, B., Luo, S., Zhen, X., Fan, M., Liu, T., Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors (2011) PLoS One, 6, p. 21896; Ye, J., Farnum, M., Yang, E., Verbeeck, R., Lobanov, V., Raghavan, N., Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data (2012) BMC Neurol, 12, p. 46; Gomar, J.J., Bobes-Bascaran, M.T., Conejero-Goldberg, C., Davies, P., Goldberg, T.E., Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative (2011) Arch Gen Psychiatry, 68, pp. 961-969; Mattila, J., Koikkalainen, J., Virkki, A., Simonsen, A., Van Gils, M., Waldemar, G., A disease state fingerprint for evaluation of Alzheimer's disease (2011) J Alzheimer Dis, 27, pp. 163-176; Shaffer, J.L., Petrella, J.R., Sheldon, F.C., Choudhury, K.R., Calhoun, V.D., Coleman, R.E., Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers (2013) Radiology, 266, pp. 583-591; Chen, K., Ayutyanont, N., Langbaum, J.B., Fleisher, A.S., Reschke, C., Lee, W., Characterizing Alzheimer's disease using a hypometabolic convergence index (2011) Neuroimage, 56, pp. 52-60; Landau, S.M., Harvey, D., Madison, C.M., Reiman, E.M., Foster, N.L., Aisen, P.S., Comparing predictors of conversion and decline in mild cognitive impairment (2010) Neurology, 75, pp. 230-238; Zhang, D., Shen, D., Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers (2012) PLoS One, 7, p. 33182; Jack, Jr.C.R., Barkhof, F., Bernstein, M.A., Cantillon, M., Cole, P.E., Decarli, C., Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease (2011) Alzheimer Dement, 7, pp. 474-485. , e474
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-84896330212&partnerID=40&md5=d3b2af13de9567b1d4ae00cf9f2770b6
Author Address: Imaging Genetics Center, Keck School of Medicine, University of Southern California, 4676 Admiralty Way, Marina Del Rey, CA 90292, United States
Department of Neurology, University of Southern California, Los Angeles, CA, United States
Department of Psychiatry and Behavioral Sciences, University of Southern California, Los Angeles, CA, United States
Department of Radiology, University of Southern California, Los Angeles, CA, United States
Department of Pediatrics, University of Southern California, Los Angeles, CA, United States
Department of Ophthalmology, University of Southern California, Los Angeles, CA, United States
Keck School of Medicine, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, United States


